1. Home
  2. NOTV vs ZGM Comparison

NOTV vs ZGM Comparison

Compare NOTV & ZGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • ZGM
  • Stock Information
  • Founded
  • NOTV 1974
  • ZGM 2019
  • Country
  • NOTV United States
  • ZGM Macau
  • Employees
  • NOTV N/A
  • ZGM N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • ZGM Professional Services
  • Sector
  • NOTV Health Care
  • ZGM Consumer Discretionary
  • Exchange
  • NOTV Nasdaq
  • ZGM Nasdaq
  • Market Cap
  • NOTV 28.7M
  • ZGM 30.0M
  • IPO Year
  • NOTV 1997
  • ZGM 2025
  • Fundamental
  • Price
  • NOTV $0.87
  • ZGM $2.50
  • Analyst Decision
  • NOTV Strong Buy
  • ZGM
  • Analyst Count
  • NOTV 1
  • ZGM 0
  • Target Price
  • NOTV $5.00
  • ZGM N/A
  • AVG Volume (30 Days)
  • NOTV 1.6M
  • ZGM 49.2K
  • Earning Date
  • NOTV 12-03-2025
  • ZGM 01-06-2026
  • Dividend Yield
  • NOTV N/A
  • ZGM N/A
  • EPS Growth
  • NOTV N/A
  • ZGM 401.52
  • EPS
  • NOTV N/A
  • ZGM 0.17
  • Revenue
  • NOTV $505,299,000.00
  • ZGM $3,620,780.00
  • Revenue This Year
  • NOTV $5.64
  • ZGM N/A
  • Revenue Next Year
  • NOTV $5.16
  • ZGM N/A
  • P/E Ratio
  • NOTV N/A
  • ZGM $13.92
  • Revenue Growth
  • NOTV 0.85
  • ZGM 211.78
  • 52 Week Low
  • NOTV $0.66
  • ZGM $1.90
  • 52 Week High
  • NOTV $6.48
  • ZGM $4.51
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 36.75
  • ZGM N/A
  • Support Level
  • NOTV $0.77
  • ZGM N/A
  • Resistance Level
  • NOTV $0.86
  • ZGM N/A
  • Average True Range (ATR)
  • NOTV 0.13
  • ZGM 0.00
  • MACD
  • NOTV -0.01
  • ZGM 0.00
  • Stochastic Oscillator
  • NOTV 35.07
  • ZGM 0.00

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About ZGM Zenta Group Company Limited Ordinary Shares

Zenta Group Co Ltd is engaged in the provision of industrial park consultation services, business investment consultation services to clients through LIC, and sales of fintech products and services through LFT. Its industrial park consultation services are focused on the pre-development stage. Its business investment consultation services, offered through LIC, mainly focus on assisting clients to acquire stakes in specific investments, and it's normally in the form of equity ownership.

Share on Social Networks: